OpGen, In-Q-Tel Developing Technology for Microbial Genome Analysis | GenomeWeb

NEW YORK (GenomeWeb News) – OpGen today announced a collaboration with In-Q-Tel to develop a high-throughput sequence and genome mapping pipeline for microbial genome analysis.

The firms are developing the technology for the US Department of Homeland Security Science and Technology Directorate, a customer agency of In-Q-Tel, and the National Bioforensic Analysis Center, a DHS S&T laboratory.

In-Q-Tel, based in Arlington, Va., is an independent strategic investment firm that identifies technologies that support the missions of the US intelligence community.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.

Mar
30
Sponsored by
SeraCare

Our roundtable of industry experts will provide an overview of the current regulatory landscape for clinical genomics tests.

Apr
13
Sponsored by
SeraCare

In this webinar, Gregory J. Tsongalis of Dartmouth Hitchcock Medical Center will discuss how his lab developed and validated a cancer hotspot assay. 

Apr
27
Sponsored by
SeraCare

This webinar is the third in a four-part series highlighting real-world examples of how some lab directors are bringing validated next-generation sequencing-based tests to the clinic.

May
09
Sponsored by
SeraCare

This webinar is the last in a four-part series highlighting real-world examples of how some lab directors are bringing validated next-generation sequencing-based tests to the clinic.